ConductScience.org, home

Paper8109916

Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.

Chen M and 7 others. Antimicrob Agents Chemother, 1993. Cited by 140 papers, by iCite.

Cite this record

ConductScience Library. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Papers, record 8109916. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8109916

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1993
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
140
iCite
Relative citation ratio, by iCite
5.46
iCite
Revised in PubMed
2021-05-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen MM
2Christensen SBS B
3Blom JJ
4Lemmich EE
5Nadelmann LL
6Fich KK
7Theander TGT G
8Kharazmi AA

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiprotozoal AgentsMajor topic
ChalconeMajor topic
Leishmania donovaniMajor topic
Leishmania majorMajor topic
Leishmaniasis, CutaneousMajor topic
Leishmaniasis, VisceralMajor topic
Plant ExtractsMajor topic
Animals
Chalcones
Dose-Response Relationship, Drug
Drugs, Chinese Herbal
Humans
Leukocytes
Macrophages
Mice
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11956959Antiprotozoal agents from plant sources.Planta Med1991https://conductscience.org/library/papers/1956959PubMed
2196028Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases.J Infect Dis1977https://conductscience.org/library/papers/196028PubMed
33787684Effect of chloroquine on human lymphocyte proliferation.Trans R Soc Trop Med Hyg1986https://conductscience.org/library/papers/3787684PubMed
42360830Berberine derivatives as antileishmanial drugs.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2360830PubMed
56638989Activity of purine analogs against Leishmania tropica within human macrophages in vitro.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6638989PubMed
63124733Molecular target of the antileishmanial action of sinefungin.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3124733PubMed
72392684Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin.Science1990https://conductscience.org/library/papers/2392684PubMed
83293160Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.Rev Infect Dis1988https://conductscience.org/library/papers/3293160PubMed
91898600Macrophage activation for intracellular killing as induced by calcium ionophore. Correlation with biologic and biochemical events.J Immunol1991https://conductscience.org/library/papers/1898600PubMed
1015463585Estimation of population at risk of infection and number of cases of Leishmaniasis.Parasitol Today1992https://conductscience.org/library/papers/15463585PubMed
113014012Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism.J Infect Dis1986https://conductscience.org/library/papers/3014012PubMed
121738379Allopurinol in the treatment of American cutaneous leishmaniasis.N Engl J Med1992https://conductscience.org/library/papers/1738379PubMed
133435106In vitro activity of sulfonamides and sulfones against Leishmania major promastigotes.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3435106PubMed
141906917Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis.J Lab Clin Med1991https://conductscience.org/library/papers/1906917PubMed
156249874An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.J Infect Dis1980https://conductscience.org/library/papers/6249874PubMed
162605703Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang origin.Chem Pharm Bull (Tokyo)1989https://conductscience.org/library/papers/2605703PubMed
172632045Phenolic constituents of licorice. II. Structures of licopyranocoumarin, licoarylcoumarin and glisoflavone, and inhibitory effects of licorice phenolics on xanthine oxidase.Chem Pharm Bull (Tokyo)1989https://conductscience.org/library/papers/2632045PubMed
186712205Biological action of inosine analogs in Leishmania and Trypanosoma spp.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6712205PubMed
196732225Antileishmanial activity of chlorpromazine.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6732225PubMed
206327528Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.Infect Immun1984https://conductscience.org/library/papers/6327528PubMed

See all 28 referencesDownload CSV of references

Cited by44

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.

PMIDTitleJournalYearIn PapersSource
42357280Cross-Species Hepatic Metabolism of the Antileishmanial Chalcone NAT22 Generates Metabolites with Predicted Enhanced Affinity for the Parasite Target cTXNPx.Pharmaceutics2026https://conductscience.org/library/papers/42357280PubMed
41181588Therapeutic potential of Licochalcone A in dermatological diseases: from basic to clinical research.Front Pharmacol2025https://conductscience.org/library/papers/41181588PubMed
41155147Recent Advances in the Synthesis and Biological Applications of Prenylated Chalcones.Int J Mol Sci2025https://conductscience.org/library/papers/41155147PubMed
40599794Pharmacological potential of natural chalcones: a recent studies and future perspective.Front Pharmacol2025https://conductscience.org/library/papers/40599794PubMed
40284397Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone.Pharmaceutics2025https://conductscience.org/library/papers/40284397PubMed
39650850Identification of Coumarin-Chalcone and Coumarin-Pyrazoline Derivatives as Novel Anti-Toxoplasma gondii Agents.Drug Des Devel Ther2024https://conductscience.org/library/papers/39650850PubMed
38937401Significance of Chalcone Scaffolds in Medicinal Chemistry.Top Curr Chem (Cham)2024https://conductscience.org/library/papers/38937401PubMed
38303536An Insight into Synthetic Strategies, SAR Study and Anticancer Mechanism of Chalcone Derivatives: Medicinal Chemistry Perspective.Curr Drug Res Rev2025https://conductscience.org/library/papers/38303536PubMed
36827107Salt-Tolerant Plants as Sources of Antiparasitic Agents for Human Use: A Comprehensive Review.Mar Drugs2023https://conductscience.org/library/papers/36827107PubMed
36474507Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects.Onco Targets Ther2022https://conductscience.org/library/papers/36474507PubMed
36306047Synthesis, characterization and evaluation of prenylated chalcones ethers as promising antileishmanial compounds.Mol Divers2023https://conductscience.org/library/papers/36306047PubMed
36296655Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives.Molecules2022https://conductscience.org/library/papers/36296655PubMed
35744875Synthesis and Characterization of Novel Heterocyclic Chalcones from 1-Phenyl-1H-pyrazol-3-ol.Molecules2022https://conductscience.org/library/papers/35744875PubMed
35493668Synthesis and in vitro anti-proliferative evaluation of naphthalimide-chalcone/pyrazoline conjugates as potential SERMs with computational validation.RSC Adv2020https://conductscience.org/library/papers/35493668PubMed
35434631Identification of 2-arylquinazolines with alkyl-polyamine motifs as potent antileishmanial agents: synthesis and biological evaluation studies.RSC Med Chem2022https://conductscience.org/library/papers/35434631PubMed
34977998Antimalarial Natural Products.Prog Chem Org Nat Prod2022https://conductscience.org/library/papers/34977998PubMed
34660960Synthesis, Structural Characterizations, and Quantum Chemical Investigations on 1-(3-Methoxy-phenyl)-3-naphthalen-1-yl-propenone.ACS Omega2021https://conductscience.org/library/papers/34660960PubMed
34187608Moringa oleifera extract promotes apoptosis-like death in Toxoplasma gondii tachyzoites in vitro.Parasitology2021https://conductscience.org/library/papers/34187608PubMed
33536909Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence.Front Pharmacol2020https://conductscience.org/library/papers/33536909PubMed
33363224Licochalcone a Exhibits Leishmanicidal Activity in vitro and in Experimental Model of Leishmania (Leishmania) Infantum.Front Vet Sci2020https://conductscience.org/library/papers/33363224PubMed

See all 44 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8109916

GET https://conductscience.org/api/papers/v1/8109916/references?page=2